Skip to content
God Of Sound – Lifestyle
Author:
Allogenetics GmbH
Allogenetics Appoints Dr. Olaf Schermeier as Chairman of the Advisory Board
October 1, 2026
Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes
September 9, 2026
Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer
July 21, 2026